Status:
RECRUITING
Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Retinoblastoma
Eligibility:
All Genders
Brief Summary
Retinoblastoma is the most frequent intraocular tumor in children and represents 6% of all pediatric cancers before the age of 5 years-old. The outcome is now excellent with 95 to 97% of 5-years survi...
Eligibility Criteria
Inclusion
- grade B to D retinoblastoma
- prescription of intra arterial chemotherapy
Exclusion
- none
Key Trial Info
Start Date :
January 11 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2030
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03267459
Start Date
January 11 2018
End Date
July 1 2030
Last Update
January 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondation A De Rothschild
Paris, France, 75019